Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CDIO | US
0.02
9.53%
Healthcare
Biotechnology
30/06/2024
21/10/2024
0.23
0.22
0.24
0.21
Cardio Diagnostics Holdings Inc. an artificial intelligence-powered precision cardiovascular medicine company develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events including heart attacks; and PrecisionCHD an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. The company was founded in 2017 and is headquartered in Chicago Illinois.
View LessValue Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
75.7%1 month
87.9%3 months
87.8%6 months
91.0%-
-
2.10
0.28
0.22
-22.48
151.27
-
-8.22M
7.07M
7.07M
-
-16.30K
-
356.20
-293.27
1.55
13.77
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.09
Range1M
0.10
Range3M
0.35
Rel. volume
0.99
Price X volume
681.36K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Alzamend Neuro Inc. Common Stock | ALZN | Biotechnology | 1.73 | 7.74M | 3.28% | n/a | 0.00% |
Moleculin Biotech Inc | MBRX | Biotechnology | 2.67 | 7.59M | 3.29% | n/a | 3.00% |
Pulmatrix Inc | PULM | Biotechnology | 2.04 | 7.45M | 0.97% | n/a | 0.18% |
Cyclerion Therapeutics Inc | CYCN | Biotechnology | 2.9099 | 7.32M | 16.40% | n/a | 0.00% |
Orgenesis Inc | ORGS | Biotechnology | 1.53 | 7.30M | -27.49% | n/a | -84.02% |
Virax Biolabs Group Limited Ordinary Shares | VRAX | Biotechnology | 1.63 | 7.08M | 6.54% | n/a | 4.18% |
Purple Biotech Ltd | PPBT | Biotechnology | 4.49 | 7.07M | 2.75% | n/a | 0.89% |
Galmed Pharmaceuticals Ltd | GLMD | Biotechnology | 4.68 | 7.05M | 23.16% | n/a | 0.00% |
Vaccinex Inc - Ordinary Shares | VCNX | Biotechnology | 2.69 | 6.99M | 6.32% | n/a | -4.26% |
Aptose Biosciences Inc | APTO | Biotechnology | 0.3889 | 6.96M | 6.75% | n/a | -37.59% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5263 | 7.69M | -2.17% | 0.03 | 16.03% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4659 | 4.44M | -2.96% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.19 | 2.99M | -13.68% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.71M | 0.00% | n/a | 17.32% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.65 | 2.01M | -6.89% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 1.01M | 10.00% | n/a | -37.05% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -22.48 | 0.53 | Cheaper |
Ent. to Revenue | 151.27 | 3,967.00 | Cheaper |
PE Ratio | - | 41.03 | - |
Price to Book | 2.10 | 15.55 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 87.75 | 72.80 | Riskier |
Debt to Equity | 0.28 | -1.23 | Expensive |
Debt to Assets | 0.22 | 0.25 | Par |
Market Cap | 7.07M | 3.66B | Emerging |